Stay updated on Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.

Latest updates to the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check45 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference5%
- Check53 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check67 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check74 days agoChange DetectedThe website has updated the intervention type to 'Verified 2019-12 by Henan Cancer Hospital' and noted that the last known status is 'Recruiting', while the previous revision (v2.13.3) has been removed.SummaryDifference3%
- Check103 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.